Signet‐ring cell carcinoma component in primary lung adenocarcinoma: potential prognostic factor

T. Iwasaki,M. Ohta,A. Lefor,K. Kawahara
DOI: https://doi.org/10.1111/j.1365-2559.2008.02987.x
2008-04-01
Histopathology
Abstract:P582S mutation in the oxygen-dependent degradation domain of HIF-1alpha is associated with increased risk for prostate cancer. Prostate 2007; 67; 8–13. 2. Kuwai T, Kitadai Y, Tanaka S et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol. Rep. 2004; 12; 1033–1037. 3. Vleugel MM, Greijer AE, van der Wall E et al. Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer. Cancer Genet. Cytogenet. 2005; 163; 168– 172. 4. Horree N, van Diest PJ, van der Groep P et al. Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol. 2007; 29; 219–227. 5. Clifford SC, Astuti D, Hooper L et al. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001; 20; 5067–5074. 6. Fransen K, Fenech M, Fredrikson M et al. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol. Carcinog. 2006; 45; 833–840. 7. Fu XS, Choi E, Bubley GJ et al. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005; 63; 215–221.
What problem does this paper attempt to address?